Fig. 2From: Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination ProgrammeActivity framework for the operational manual for pharmacovigilance for visceral leishmaniasis in BangladeshBack to article page